Camel Group Co., Ltd. (SHA:601311)

Market Cap	10.68B
Revenue (ttm)	15.59B
Net Income (ttm)	613.97M
Shares Out	1.17B
EPS (ttm)	0.52
PE Ratio	17.50
Forward PE	13.19
Dividend	0.27 (2.97%)
Ex-Dividend Date	Jul 4, 2025

Volume	13,755,131
Average Volume	23,947,630
Open	9.10
Previous Close	9.10
Day's Range	9.04 - 9.14
52-Week Range	6.82 - 9.63
Beta	0.63
RSI	51.73
Earnings Date	Aug 22, 2025

About Ligand Pharmaceuticals

Camel Group Co., Ltd. manufactures and sells green lead-acid and new energy lithium-ion batteries in Mainland China and Internationally. The company offers batteries for automotive, heavy commercial vehicle, golf carts, marine, and electric forklifts; and energy storage systems. It also engages in recycling of waste lead-acid batteries; and treatment and recycling of lead materials. The company sells its products under the Camel, Camel Energy, Hitec, Swan, Huazhong, and DF name. Camel Group Co., Ltd. was founded in 1980 and is headquartered in ...

• Industry: Auto Parts
• Sector: Consumer Discretionary
• Founded: 1980
• Employees: 7,473
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 601311

Financial Performance

In 2024, Camel Group's revenue was 15.59 billion, an increase of 10.75% compared to the previous year's 14.08 billion. Earnings were 613.97 million, an increase of 7.26%.